Clinical Pathways in Stroke Rehabilitation : : Evidence-Based Clinical Practice Recommendations.

Saved in:
Bibliographic Details
:
Place / Publishing House:Cham : : Springer International Publishing AG,, 2021.
©2021.
Year of Publication:2021
Edition:1st ed.
Language:English
Online Access:
Physical Description:1 online resource (284 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 5006455780
ctrlnum (MiAaPQ)5006455780
(Au-PeEL)EBL6455780
(OCoLC)1232279931
collection bib_alma
record_format marc
spelling Platz, Thomas.
Clinical Pathways in Stroke Rehabilitation : Evidence-Based Clinical Practice Recommendations.
1st ed.
Cham : Springer International Publishing AG, 2021.
©2021.
1 online resource (284 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Intro -- Preface -- Acknowledgements -- Contents -- Neurobiology of Stroke Recovery -- 1 Changes in Structural Plasticity After Stroke -- 2 Changes in Functional Plasticity After Stroke -- 3 Conclusion Regarding the Neurobiology of Stroke Recovery -- 4 Take Home Message for Clinical Practice in Stroke Rehabilitation -- References -- Clinical Pathways in Stroke Rehabilitation: Background, Scope, and Methods -- 1 Introduction -- 2 Clinical Pathways -- 3 The Evidence Gap -- 4 International Provision of Practice Recommendations -- 5 Scope, Content, and Methodology Used for the Generation of the Practice Recommendations -- 5.1 Scope of the Evidence-Based Clinical Practice Recommendations -- 5.2 Target Users of the Practice Recommendations -- 5.3 Stakeholder Involvement -- 5.3.1 Practice Recommendations Developer Group -- 5.3.2 Integration of Views and Preferences of the Target Population -- 5.4 Methods Used for Evidence Synthesis and Recommendation Development -- 5.4.1 General Remarks -- 5.4.2 Systematic Search -- 5.4.3 Criteria and Methods for Evidence Selection and Data Extraction -- 5.4.4 Critical Appraisal, Level of Evidence, Evidence Synthesis, and Grading its Quality -- 5.4.5 Synthesis of Evidence-Based Recommendations -- 5.4.6 Dissemination, Implementation, Monitoring, and Auditing -- 5.4.7 Process of Updating the Clinical Practice Recommendations -- 5.4.8 Funding of the Work -- 6 Conclusions -- References -- Goal Setting with ICF (International Classification of Functioning, Disability and Health) and Multidisciplinary Team Approach in Stroke Rehabilitation -- 1 Introduction -- 2 Methodological Considerations -- 3 Multidisciplinary Team Building and Coordination -- 3.1 Improving Quality of Stroke Care -- 3.2 Low Access to Rehabilitation -- 3.3 The Chronic Care Model for Stroke Patients.
4 ICF-Based Common Language in Reporting and Documentation Along the Care Pathway of Stroke Patients -- 4.1 ICF-Based Scales and Assessments -- 4.2 ICF-Based Goal Setting -- 5 Theoretical Background in Goal-Setting Practice -- 5.1 Goal-Setting Theory (Locke and Latham) -- 5.2 Goal Setting and Action Planning (Scobbie) -- 5.3 Goal Achievement and Goal Attainment Scaling -- 5.4 Examples on ICF-Based Goal Setting -- 6 Goal Setting in Stroke Patients in Practice -- 7 Recommendations for Multidisciplinary Team Approach and ICF-Based Goal Setting in Stroke Rehabilitation -- 8 Summary -- References -- Disorders of Consciousness -- 1 Introduction -- 2 Methods -- 3 DoC Assessment: Clinical Behavioral and Instrumental Diagnostic Tools -- 3.1 Clinicals and Behavioral Tools for DoC Assessments -- 3.2 Instrumental Diagnostic Tools for DoC Assessment -- 4 DoC Rehabilitation -- 5 Pharmacological Therapies for DoC -- 6 Other Specific Therapies for DoC -- References -- Airway and Ventilation Management -- 1 Introduction -- 2 Clinical Evidence and Reasoning -- 2.1 Weaning of Neurological Patients -- 2.2 Existing Studies on Weaning Success -- 2.3 Difficulties in the Weaning Process -- 2.4 Weaning Strategies -- 2.5 Weaning Protocols and Special Ventilation Techniques -- 2.6 Special Features of Prolonged Weaning in Neurological Patients -- 2.6.1 Definition of Successful Weaning from Mechanical Ventilation -- 2.6.2 Invasive and Non-Invasive Ventilation -- 2.6.3 Accompanying Neurological-Neurosurgical (Early) Rehabilitation -- 3 Clinical Practice Recommendations for Weaning in Stroke Patients (and Other Patients with Neurological Conditions) -- 3.1 Methodological Explanations -- 3.2 Recommendations -- 3.2.1 Organizational Setting -- 3.2.2 Weaning Strategy -- 3.2.3 Weaning Process Characteristics -- References -- Recovery of Swallowing.
1 Introduction -- 2 Dysphagia Screening Early after Stroke -- 3 Instrumental Assessments to Detect Dysphagia or Aspiration -- 4 Treatment of Dysphagia -- 4.1 Behavioral Interventions -- 4.2 Neuromuscular Electrical Stimulation (NMES) -- 4.3 Acupuncture -- 4.4 Noninvasive Brain Stimulation (NIBS) -- 4.5 Oral Hygiene -- 5 Enteral Tube Feedings -- 6 Summary -- References -- Arm Rehabilitation -- 1 Introduction -- 2 Methods for the Best Evidence Synthesis -- 3 Assessment -- 3.1 Measures of Impairment -- 3.1.1 Active Motor Control -- 3.1.2 Spasticity/Resistance to Passive Movement -- 3.2 Measures of Arm, Hand, and/or Finger Function -- 3.3 Measure of Self-Perceived Usefulness of the Affected Arm in Daily Life -- 4 Therapy -- 4.1 Training -- 4.1.1 Dosage of the Therapeutic Time Prescribed and Organizational Forms of Therapy -- 4.1.2 "Schools" of Therapy -- 4.1.3 Type of Feedback Given -- 4.1.4 Bilateral Training -- 4.1.5 Impairment-Oriented Training -- 4.1.6 Task-Specific Training -- 4.1.7 Constraint-Induced Movement Therapy (CIMT) -- 4.1.8 Strength Training -- 4.1.9 Mirror Therapy -- 4.1.10 Mental Practice -- 4.1.11 Action Observation -- 4.1.12 Music Therapy and Rhythmic Auditory Stimulation -- 4.2 Technology-Supported Training -- 4.2.1 Passive Devices for Repetitive Arm and Hand Training -- 4.2.2 Trunk Restraint -- 4.2.3 Splints and Strapping -- 4.2.4 Arm Rehabilitation Using Virtual Reality (VR) Applications -- 4.2.5 EMG- and Neuro-Biofeedback -- 4.2.6 Neuromuscular Electrical Stimulation (NMES) -- 4.2.7 Arm Robot Therapy -- 4.2.8 Repetitive Transcranial Magnetic Stimulation (rTMS) -- 4.2.9 Repetitive Peripheral Magnetic Stimulation (rPMS) -- 4.2.10 Transcranial Direct Current Stimulation (tDCS) -- 4.2.11 Somatosensory Stimulation -- 4.2.12 Acupuncture -- 4.2.13 Investigational Devices -- 4.3 Medication.
4.3.1 Botulinum Neurotoxin A (BoNT A) -- 4.3.2 Drugs to Enhance Recovery -- 5 Clinical Pathway and Practice Recommendations -- 5.1 General Comments -- 5.2 Dosage and Organization of Treatment -- 5.2.1 Acute and Subacute Phase After Stroke -- 5.2.2 Chronic Phase After Stroke -- 5.3 Therapeutic Options (Table 1) -- 5.3.1 Therapeutic Options for Stroke Survivors with Severe Paresis -- 5.3.2 Therapeutic Options for Stroke Survivors with Moderate and Mild Paresis -- 5.3.3 Therapeutic Options Independent of Stage of Disease or Severity of Paresis -- References -- Mobility After Stroke: Relearning to Walk -- 1 Introduction -- 2 Best Evidence for Rehabilitations of Gait: Methodology -- 3 Early Intensive Training in the Acute Phase (24 H) After Stroke -- 4 Restoration of Gait in Severely Affected Patients Who cannot Walk Without Help -- 4.1 Discussion: Restoration of Gait in Non-Ambulatory Patients -- 4.2 Summary -- 5 Improvement of Gait in Patients Who Walk Independently or With Little Help -- 5.1 Discussion: Improving Walking Ability in Ambulatory and Nearly Ambulatory Patients -- 5.2 Summary -- 6 Improvement of Balance, Reduction of Falls -- 6.1 Discussion: Improvement of Balance, Reduction of Falls -- 6.2 Summary -- 7 Improvement of Walking Speed -- 7.1 Discussion: Improvement of Walking Speed -- 7.2 Summary -- 8 Improvement of Walking Distance -- 8.1 Discussion: Increasing Walking Distance -- 8.2 Summary -- 9 General Discussion and Conclusions -- References -- Post-Stroke Spasticity -- 1 Introduction -- 2 Methods Used for Evidence Synthesis and Practice Recommendations -- 3 Problem Identification and Clinical Assessment -- 4 Treatment Goal Setting -- 4.1 Goal Setting -- 4.2 Goal Attainment Scaling -- 5 Pharmacological and Surgical Treatment -- 5.1 Systemic Medications -- 5.2 Botulinum Toxin Treatment.
5.2.1 Treatment Outcomes: Upper Limbs -- 5.2.2 Treatment Outcomes: Lower Limbs -- 5.2.3 Treatment Outcomes: Spasticity- or Spasm-Associated Pain -- 5.2.4 Botulinum Toxin A Injection Guidance -- 5.2.5 BoNT-A Products -- 5.2.6 BoNT-A Dosing -- 5.2.7 Adjuvant Therapies to BoNT-A -- 5.3 Neurolysis -- 5.4 Intrathecal Baclofen (ITB) -- 5.5 Surgical Management -- References -- Rehabilitation of Communication Disorders -- 1 Introduction: The Clinical Problem -- 1.1 Aphasia -- 1.2 Dysarthria -- 1.3 Apraxia -- 2 Recommendations for the Assessment and Treatment of Post-Stroke Communication Disorders -- 2.1 Clinical Assessment of Communication Disorders -- 2.2 Behavioural Therapy Interventions -- 2.2.1 Aphasia Therapy -- Impairment Focus -- Activity/Participation Focus -- 2.2.2 Dysarthria Therapy -- 2.2.3 Apraxia of Speech -- 2.3 Biological Therapies -- 2.3.1 Pharmacological Treatments -- 2.3.2 Non-Invasive Brain Stimulation (NIBS) -- 2.4 Timing, Intensity, Dose and Duration of Therapy -- 2.4.1 Timing -- 2.4.2 Intensity, Dose and Duration -- 2.5 Methods of Therapy Delivery -- 2.5.1 Group Therapy -- 2.5.2 Use of Volunteers -- 2.5.3 Use of Computers/Telepractice -- 2.6 Alternative and Augmentative Communication -- 2.7 Communication Environment -- 2.7.1 Conversation/Communication Partner Training -- 2.8 Psychosocial Interventions to Manage Mood Disorders Secondary to Aphasia -- 3 Top Ten Best Practice Recommendations for Aphasia and Forthcoming Information -- References -- Treating Neurovisual Deficits and Spatial Neglect -- 1 Neurovisual Disorders After Brain Damage -- 1.1 Assessment of Neurovisual Disorders -- 1.2 Therapy of Neurovisual Disorders -- 1.2.1 Saccadic Compensation (or Scanning) Training -- 1.2.2 Hemianopic Reading Training -- 1.2.3 Compensatory or Restorative Visual Field Training?.
1.2.4 Ineffective or Disadvantageous Therapies in VFDs.
Description based on publisher supplied metadata and other sources.
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
Electronic books.
Print version: Platz, Thomas Clinical Pathways in Stroke Rehabilitation Cham : Springer International Publishing AG,c2021 9783030585044
ProQuest (Firm)
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6455780 Click to View
language English
format eBook
author Platz, Thomas.
spellingShingle Platz, Thomas.
Clinical Pathways in Stroke Rehabilitation : Evidence-Based Clinical Practice Recommendations.
Intro -- Preface -- Acknowledgements -- Contents -- Neurobiology of Stroke Recovery -- 1 Changes in Structural Plasticity After Stroke -- 2 Changes in Functional Plasticity After Stroke -- 3 Conclusion Regarding the Neurobiology of Stroke Recovery -- 4 Take Home Message for Clinical Practice in Stroke Rehabilitation -- References -- Clinical Pathways in Stroke Rehabilitation: Background, Scope, and Methods -- 1 Introduction -- 2 Clinical Pathways -- 3 The Evidence Gap -- 4 International Provision of Practice Recommendations -- 5 Scope, Content, and Methodology Used for the Generation of the Practice Recommendations -- 5.1 Scope of the Evidence-Based Clinical Practice Recommendations -- 5.2 Target Users of the Practice Recommendations -- 5.3 Stakeholder Involvement -- 5.3.1 Practice Recommendations Developer Group -- 5.3.2 Integration of Views and Preferences of the Target Population -- 5.4 Methods Used for Evidence Synthesis and Recommendation Development -- 5.4.1 General Remarks -- 5.4.2 Systematic Search -- 5.4.3 Criteria and Methods for Evidence Selection and Data Extraction -- 5.4.4 Critical Appraisal, Level of Evidence, Evidence Synthesis, and Grading its Quality -- 5.4.5 Synthesis of Evidence-Based Recommendations -- 5.4.6 Dissemination, Implementation, Monitoring, and Auditing -- 5.4.7 Process of Updating the Clinical Practice Recommendations -- 5.4.8 Funding of the Work -- 6 Conclusions -- References -- Goal Setting with ICF (International Classification of Functioning, Disability and Health) and Multidisciplinary Team Approach in Stroke Rehabilitation -- 1 Introduction -- 2 Methodological Considerations -- 3 Multidisciplinary Team Building and Coordination -- 3.1 Improving Quality of Stroke Care -- 3.2 Low Access to Rehabilitation -- 3.3 The Chronic Care Model for Stroke Patients.
4 ICF-Based Common Language in Reporting and Documentation Along the Care Pathway of Stroke Patients -- 4.1 ICF-Based Scales and Assessments -- 4.2 ICF-Based Goal Setting -- 5 Theoretical Background in Goal-Setting Practice -- 5.1 Goal-Setting Theory (Locke and Latham) -- 5.2 Goal Setting and Action Planning (Scobbie) -- 5.3 Goal Achievement and Goal Attainment Scaling -- 5.4 Examples on ICF-Based Goal Setting -- 6 Goal Setting in Stroke Patients in Practice -- 7 Recommendations for Multidisciplinary Team Approach and ICF-Based Goal Setting in Stroke Rehabilitation -- 8 Summary -- References -- Disorders of Consciousness -- 1 Introduction -- 2 Methods -- 3 DoC Assessment: Clinical Behavioral and Instrumental Diagnostic Tools -- 3.1 Clinicals and Behavioral Tools for DoC Assessments -- 3.2 Instrumental Diagnostic Tools for DoC Assessment -- 4 DoC Rehabilitation -- 5 Pharmacological Therapies for DoC -- 6 Other Specific Therapies for DoC -- References -- Airway and Ventilation Management -- 1 Introduction -- 2 Clinical Evidence and Reasoning -- 2.1 Weaning of Neurological Patients -- 2.2 Existing Studies on Weaning Success -- 2.3 Difficulties in the Weaning Process -- 2.4 Weaning Strategies -- 2.5 Weaning Protocols and Special Ventilation Techniques -- 2.6 Special Features of Prolonged Weaning in Neurological Patients -- 2.6.1 Definition of Successful Weaning from Mechanical Ventilation -- 2.6.2 Invasive and Non-Invasive Ventilation -- 2.6.3 Accompanying Neurological-Neurosurgical (Early) Rehabilitation -- 3 Clinical Practice Recommendations for Weaning in Stroke Patients (and Other Patients with Neurological Conditions) -- 3.1 Methodological Explanations -- 3.2 Recommendations -- 3.2.1 Organizational Setting -- 3.2.2 Weaning Strategy -- 3.2.3 Weaning Process Characteristics -- References -- Recovery of Swallowing.
1 Introduction -- 2 Dysphagia Screening Early after Stroke -- 3 Instrumental Assessments to Detect Dysphagia or Aspiration -- 4 Treatment of Dysphagia -- 4.1 Behavioral Interventions -- 4.2 Neuromuscular Electrical Stimulation (NMES) -- 4.3 Acupuncture -- 4.4 Noninvasive Brain Stimulation (NIBS) -- 4.5 Oral Hygiene -- 5 Enteral Tube Feedings -- 6 Summary -- References -- Arm Rehabilitation -- 1 Introduction -- 2 Methods for the Best Evidence Synthesis -- 3 Assessment -- 3.1 Measures of Impairment -- 3.1.1 Active Motor Control -- 3.1.2 Spasticity/Resistance to Passive Movement -- 3.2 Measures of Arm, Hand, and/or Finger Function -- 3.3 Measure of Self-Perceived Usefulness of the Affected Arm in Daily Life -- 4 Therapy -- 4.1 Training -- 4.1.1 Dosage of the Therapeutic Time Prescribed and Organizational Forms of Therapy -- 4.1.2 "Schools" of Therapy -- 4.1.3 Type of Feedback Given -- 4.1.4 Bilateral Training -- 4.1.5 Impairment-Oriented Training -- 4.1.6 Task-Specific Training -- 4.1.7 Constraint-Induced Movement Therapy (CIMT) -- 4.1.8 Strength Training -- 4.1.9 Mirror Therapy -- 4.1.10 Mental Practice -- 4.1.11 Action Observation -- 4.1.12 Music Therapy and Rhythmic Auditory Stimulation -- 4.2 Technology-Supported Training -- 4.2.1 Passive Devices for Repetitive Arm and Hand Training -- 4.2.2 Trunk Restraint -- 4.2.3 Splints and Strapping -- 4.2.4 Arm Rehabilitation Using Virtual Reality (VR) Applications -- 4.2.5 EMG- and Neuro-Biofeedback -- 4.2.6 Neuromuscular Electrical Stimulation (NMES) -- 4.2.7 Arm Robot Therapy -- 4.2.8 Repetitive Transcranial Magnetic Stimulation (rTMS) -- 4.2.9 Repetitive Peripheral Magnetic Stimulation (rPMS) -- 4.2.10 Transcranial Direct Current Stimulation (tDCS) -- 4.2.11 Somatosensory Stimulation -- 4.2.12 Acupuncture -- 4.2.13 Investigational Devices -- 4.3 Medication.
4.3.1 Botulinum Neurotoxin A (BoNT A) -- 4.3.2 Drugs to Enhance Recovery -- 5 Clinical Pathway and Practice Recommendations -- 5.1 General Comments -- 5.2 Dosage and Organization of Treatment -- 5.2.1 Acute and Subacute Phase After Stroke -- 5.2.2 Chronic Phase After Stroke -- 5.3 Therapeutic Options (Table 1) -- 5.3.1 Therapeutic Options for Stroke Survivors with Severe Paresis -- 5.3.2 Therapeutic Options for Stroke Survivors with Moderate and Mild Paresis -- 5.3.3 Therapeutic Options Independent of Stage of Disease or Severity of Paresis -- References -- Mobility After Stroke: Relearning to Walk -- 1 Introduction -- 2 Best Evidence for Rehabilitations of Gait: Methodology -- 3 Early Intensive Training in the Acute Phase (24 H) After Stroke -- 4 Restoration of Gait in Severely Affected Patients Who cannot Walk Without Help -- 4.1 Discussion: Restoration of Gait in Non-Ambulatory Patients -- 4.2 Summary -- 5 Improvement of Gait in Patients Who Walk Independently or With Little Help -- 5.1 Discussion: Improving Walking Ability in Ambulatory and Nearly Ambulatory Patients -- 5.2 Summary -- 6 Improvement of Balance, Reduction of Falls -- 6.1 Discussion: Improvement of Balance, Reduction of Falls -- 6.2 Summary -- 7 Improvement of Walking Speed -- 7.1 Discussion: Improvement of Walking Speed -- 7.2 Summary -- 8 Improvement of Walking Distance -- 8.1 Discussion: Increasing Walking Distance -- 8.2 Summary -- 9 General Discussion and Conclusions -- References -- Post-Stroke Spasticity -- 1 Introduction -- 2 Methods Used for Evidence Synthesis and Practice Recommendations -- 3 Problem Identification and Clinical Assessment -- 4 Treatment Goal Setting -- 4.1 Goal Setting -- 4.2 Goal Attainment Scaling -- 5 Pharmacological and Surgical Treatment -- 5.1 Systemic Medications -- 5.2 Botulinum Toxin Treatment.
5.2.1 Treatment Outcomes: Upper Limbs -- 5.2.2 Treatment Outcomes: Lower Limbs -- 5.2.3 Treatment Outcomes: Spasticity- or Spasm-Associated Pain -- 5.2.4 Botulinum Toxin A Injection Guidance -- 5.2.5 BoNT-A Products -- 5.2.6 BoNT-A Dosing -- 5.2.7 Adjuvant Therapies to BoNT-A -- 5.3 Neurolysis -- 5.4 Intrathecal Baclofen (ITB) -- 5.5 Surgical Management -- References -- Rehabilitation of Communication Disorders -- 1 Introduction: The Clinical Problem -- 1.1 Aphasia -- 1.2 Dysarthria -- 1.3 Apraxia -- 2 Recommendations for the Assessment and Treatment of Post-Stroke Communication Disorders -- 2.1 Clinical Assessment of Communication Disorders -- 2.2 Behavioural Therapy Interventions -- 2.2.1 Aphasia Therapy -- Impairment Focus -- Activity/Participation Focus -- 2.2.2 Dysarthria Therapy -- 2.2.3 Apraxia of Speech -- 2.3 Biological Therapies -- 2.3.1 Pharmacological Treatments -- 2.3.2 Non-Invasive Brain Stimulation (NIBS) -- 2.4 Timing, Intensity, Dose and Duration of Therapy -- 2.4.1 Timing -- 2.4.2 Intensity, Dose and Duration -- 2.5 Methods of Therapy Delivery -- 2.5.1 Group Therapy -- 2.5.2 Use of Volunteers -- 2.5.3 Use of Computers/Telepractice -- 2.6 Alternative and Augmentative Communication -- 2.7 Communication Environment -- 2.7.1 Conversation/Communication Partner Training -- 2.8 Psychosocial Interventions to Manage Mood Disorders Secondary to Aphasia -- 3 Top Ten Best Practice Recommendations for Aphasia and Forthcoming Information -- References -- Treating Neurovisual Deficits and Spatial Neglect -- 1 Neurovisual Disorders After Brain Damage -- 1.1 Assessment of Neurovisual Disorders -- 1.2 Therapy of Neurovisual Disorders -- 1.2.1 Saccadic Compensation (or Scanning) Training -- 1.2.2 Hemianopic Reading Training -- 1.2.3 Compensatory or Restorative Visual Field Training?.
1.2.4 Ineffective or Disadvantageous Therapies in VFDs.
author_facet Platz, Thomas.
author_variant t p tp
author_sort Platz, Thomas.
title Clinical Pathways in Stroke Rehabilitation : Evidence-Based Clinical Practice Recommendations.
title_sub Evidence-Based Clinical Practice Recommendations.
title_full Clinical Pathways in Stroke Rehabilitation : Evidence-Based Clinical Practice Recommendations.
title_fullStr Clinical Pathways in Stroke Rehabilitation : Evidence-Based Clinical Practice Recommendations.
title_full_unstemmed Clinical Pathways in Stroke Rehabilitation : Evidence-Based Clinical Practice Recommendations.
title_auth Clinical Pathways in Stroke Rehabilitation : Evidence-Based Clinical Practice Recommendations.
title_new Clinical Pathways in Stroke Rehabilitation :
title_sort clinical pathways in stroke rehabilitation : evidence-based clinical practice recommendations.
publisher Springer International Publishing AG,
publishDate 2021
physical 1 online resource (284 pages)
edition 1st ed.
contents Intro -- Preface -- Acknowledgements -- Contents -- Neurobiology of Stroke Recovery -- 1 Changes in Structural Plasticity After Stroke -- 2 Changes in Functional Plasticity After Stroke -- 3 Conclusion Regarding the Neurobiology of Stroke Recovery -- 4 Take Home Message for Clinical Practice in Stroke Rehabilitation -- References -- Clinical Pathways in Stroke Rehabilitation: Background, Scope, and Methods -- 1 Introduction -- 2 Clinical Pathways -- 3 The Evidence Gap -- 4 International Provision of Practice Recommendations -- 5 Scope, Content, and Methodology Used for the Generation of the Practice Recommendations -- 5.1 Scope of the Evidence-Based Clinical Practice Recommendations -- 5.2 Target Users of the Practice Recommendations -- 5.3 Stakeholder Involvement -- 5.3.1 Practice Recommendations Developer Group -- 5.3.2 Integration of Views and Preferences of the Target Population -- 5.4 Methods Used for Evidence Synthesis and Recommendation Development -- 5.4.1 General Remarks -- 5.4.2 Systematic Search -- 5.4.3 Criteria and Methods for Evidence Selection and Data Extraction -- 5.4.4 Critical Appraisal, Level of Evidence, Evidence Synthesis, and Grading its Quality -- 5.4.5 Synthesis of Evidence-Based Recommendations -- 5.4.6 Dissemination, Implementation, Monitoring, and Auditing -- 5.4.7 Process of Updating the Clinical Practice Recommendations -- 5.4.8 Funding of the Work -- 6 Conclusions -- References -- Goal Setting with ICF (International Classification of Functioning, Disability and Health) and Multidisciplinary Team Approach in Stroke Rehabilitation -- 1 Introduction -- 2 Methodological Considerations -- 3 Multidisciplinary Team Building and Coordination -- 3.1 Improving Quality of Stroke Care -- 3.2 Low Access to Rehabilitation -- 3.3 The Chronic Care Model for Stroke Patients.
4 ICF-Based Common Language in Reporting and Documentation Along the Care Pathway of Stroke Patients -- 4.1 ICF-Based Scales and Assessments -- 4.2 ICF-Based Goal Setting -- 5 Theoretical Background in Goal-Setting Practice -- 5.1 Goal-Setting Theory (Locke and Latham) -- 5.2 Goal Setting and Action Planning (Scobbie) -- 5.3 Goal Achievement and Goal Attainment Scaling -- 5.4 Examples on ICF-Based Goal Setting -- 6 Goal Setting in Stroke Patients in Practice -- 7 Recommendations for Multidisciplinary Team Approach and ICF-Based Goal Setting in Stroke Rehabilitation -- 8 Summary -- References -- Disorders of Consciousness -- 1 Introduction -- 2 Methods -- 3 DoC Assessment: Clinical Behavioral and Instrumental Diagnostic Tools -- 3.1 Clinicals and Behavioral Tools for DoC Assessments -- 3.2 Instrumental Diagnostic Tools for DoC Assessment -- 4 DoC Rehabilitation -- 5 Pharmacological Therapies for DoC -- 6 Other Specific Therapies for DoC -- References -- Airway and Ventilation Management -- 1 Introduction -- 2 Clinical Evidence and Reasoning -- 2.1 Weaning of Neurological Patients -- 2.2 Existing Studies on Weaning Success -- 2.3 Difficulties in the Weaning Process -- 2.4 Weaning Strategies -- 2.5 Weaning Protocols and Special Ventilation Techniques -- 2.6 Special Features of Prolonged Weaning in Neurological Patients -- 2.6.1 Definition of Successful Weaning from Mechanical Ventilation -- 2.6.2 Invasive and Non-Invasive Ventilation -- 2.6.3 Accompanying Neurological-Neurosurgical (Early) Rehabilitation -- 3 Clinical Practice Recommendations for Weaning in Stroke Patients (and Other Patients with Neurological Conditions) -- 3.1 Methodological Explanations -- 3.2 Recommendations -- 3.2.1 Organizational Setting -- 3.2.2 Weaning Strategy -- 3.2.3 Weaning Process Characteristics -- References -- Recovery of Swallowing.
1 Introduction -- 2 Dysphagia Screening Early after Stroke -- 3 Instrumental Assessments to Detect Dysphagia or Aspiration -- 4 Treatment of Dysphagia -- 4.1 Behavioral Interventions -- 4.2 Neuromuscular Electrical Stimulation (NMES) -- 4.3 Acupuncture -- 4.4 Noninvasive Brain Stimulation (NIBS) -- 4.5 Oral Hygiene -- 5 Enteral Tube Feedings -- 6 Summary -- References -- Arm Rehabilitation -- 1 Introduction -- 2 Methods for the Best Evidence Synthesis -- 3 Assessment -- 3.1 Measures of Impairment -- 3.1.1 Active Motor Control -- 3.1.2 Spasticity/Resistance to Passive Movement -- 3.2 Measures of Arm, Hand, and/or Finger Function -- 3.3 Measure of Self-Perceived Usefulness of the Affected Arm in Daily Life -- 4 Therapy -- 4.1 Training -- 4.1.1 Dosage of the Therapeutic Time Prescribed and Organizational Forms of Therapy -- 4.1.2 "Schools" of Therapy -- 4.1.3 Type of Feedback Given -- 4.1.4 Bilateral Training -- 4.1.5 Impairment-Oriented Training -- 4.1.6 Task-Specific Training -- 4.1.7 Constraint-Induced Movement Therapy (CIMT) -- 4.1.8 Strength Training -- 4.1.9 Mirror Therapy -- 4.1.10 Mental Practice -- 4.1.11 Action Observation -- 4.1.12 Music Therapy and Rhythmic Auditory Stimulation -- 4.2 Technology-Supported Training -- 4.2.1 Passive Devices for Repetitive Arm and Hand Training -- 4.2.2 Trunk Restraint -- 4.2.3 Splints and Strapping -- 4.2.4 Arm Rehabilitation Using Virtual Reality (VR) Applications -- 4.2.5 EMG- and Neuro-Biofeedback -- 4.2.6 Neuromuscular Electrical Stimulation (NMES) -- 4.2.7 Arm Robot Therapy -- 4.2.8 Repetitive Transcranial Magnetic Stimulation (rTMS) -- 4.2.9 Repetitive Peripheral Magnetic Stimulation (rPMS) -- 4.2.10 Transcranial Direct Current Stimulation (tDCS) -- 4.2.11 Somatosensory Stimulation -- 4.2.12 Acupuncture -- 4.2.13 Investigational Devices -- 4.3 Medication.
4.3.1 Botulinum Neurotoxin A (BoNT A) -- 4.3.2 Drugs to Enhance Recovery -- 5 Clinical Pathway and Practice Recommendations -- 5.1 General Comments -- 5.2 Dosage and Organization of Treatment -- 5.2.1 Acute and Subacute Phase After Stroke -- 5.2.2 Chronic Phase After Stroke -- 5.3 Therapeutic Options (Table 1) -- 5.3.1 Therapeutic Options for Stroke Survivors with Severe Paresis -- 5.3.2 Therapeutic Options for Stroke Survivors with Moderate and Mild Paresis -- 5.3.3 Therapeutic Options Independent of Stage of Disease or Severity of Paresis -- References -- Mobility After Stroke: Relearning to Walk -- 1 Introduction -- 2 Best Evidence for Rehabilitations of Gait: Methodology -- 3 Early Intensive Training in the Acute Phase (24 H) After Stroke -- 4 Restoration of Gait in Severely Affected Patients Who cannot Walk Without Help -- 4.1 Discussion: Restoration of Gait in Non-Ambulatory Patients -- 4.2 Summary -- 5 Improvement of Gait in Patients Who Walk Independently or With Little Help -- 5.1 Discussion: Improving Walking Ability in Ambulatory and Nearly Ambulatory Patients -- 5.2 Summary -- 6 Improvement of Balance, Reduction of Falls -- 6.1 Discussion: Improvement of Balance, Reduction of Falls -- 6.2 Summary -- 7 Improvement of Walking Speed -- 7.1 Discussion: Improvement of Walking Speed -- 7.2 Summary -- 8 Improvement of Walking Distance -- 8.1 Discussion: Increasing Walking Distance -- 8.2 Summary -- 9 General Discussion and Conclusions -- References -- Post-Stroke Spasticity -- 1 Introduction -- 2 Methods Used for Evidence Synthesis and Practice Recommendations -- 3 Problem Identification and Clinical Assessment -- 4 Treatment Goal Setting -- 4.1 Goal Setting -- 4.2 Goal Attainment Scaling -- 5 Pharmacological and Surgical Treatment -- 5.1 Systemic Medications -- 5.2 Botulinum Toxin Treatment.
5.2.1 Treatment Outcomes: Upper Limbs -- 5.2.2 Treatment Outcomes: Lower Limbs -- 5.2.3 Treatment Outcomes: Spasticity- or Spasm-Associated Pain -- 5.2.4 Botulinum Toxin A Injection Guidance -- 5.2.5 BoNT-A Products -- 5.2.6 BoNT-A Dosing -- 5.2.7 Adjuvant Therapies to BoNT-A -- 5.3 Neurolysis -- 5.4 Intrathecal Baclofen (ITB) -- 5.5 Surgical Management -- References -- Rehabilitation of Communication Disorders -- 1 Introduction: The Clinical Problem -- 1.1 Aphasia -- 1.2 Dysarthria -- 1.3 Apraxia -- 2 Recommendations for the Assessment and Treatment of Post-Stroke Communication Disorders -- 2.1 Clinical Assessment of Communication Disorders -- 2.2 Behavioural Therapy Interventions -- 2.2.1 Aphasia Therapy -- Impairment Focus -- Activity/Participation Focus -- 2.2.2 Dysarthria Therapy -- 2.2.3 Apraxia of Speech -- 2.3 Biological Therapies -- 2.3.1 Pharmacological Treatments -- 2.3.2 Non-Invasive Brain Stimulation (NIBS) -- 2.4 Timing, Intensity, Dose and Duration of Therapy -- 2.4.1 Timing -- 2.4.2 Intensity, Dose and Duration -- 2.5 Methods of Therapy Delivery -- 2.5.1 Group Therapy -- 2.5.2 Use of Volunteers -- 2.5.3 Use of Computers/Telepractice -- 2.6 Alternative and Augmentative Communication -- 2.7 Communication Environment -- 2.7.1 Conversation/Communication Partner Training -- 2.8 Psychosocial Interventions to Manage Mood Disorders Secondary to Aphasia -- 3 Top Ten Best Practice Recommendations for Aphasia and Forthcoming Information -- References -- Treating Neurovisual Deficits and Spatial Neglect -- 1 Neurovisual Disorders After Brain Damage -- 1.1 Assessment of Neurovisual Disorders -- 1.2 Therapy of Neurovisual Disorders -- 1.2.1 Saccadic Compensation (or Scanning) Training -- 1.2.2 Hemianopic Reading Training -- 1.2.3 Compensatory or Restorative Visual Field Training?.
1.2.4 Ineffective or Disadvantageous Therapies in VFDs.
isbn 9783030585051
9783030585044
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC346-429
callnumber-sort RC 3346 3429.2
genre Electronic books.
genre_facet Electronic books.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6455780
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.8106
dewey-sort 3616.8106
dewey-raw 616.8106
dewey-search 616.8106
oclc_num 1232279931
work_keys_str_mv AT platzthomas clinicalpathwaysinstrokerehabilitationevidencebasedclinicalpracticerecommendations
status_str n
ids_txt_mv (MiAaPQ)5006455780
(Au-PeEL)EBL6455780
(OCoLC)1232279931
carrierType_str_mv cr
is_hierarchy_title Clinical Pathways in Stroke Rehabilitation : Evidence-Based Clinical Practice Recommendations.
marc_error Info : MARC8 translation shorter than ISO-8859-1, choosing MARC8. --- [ 856 : z ]
_version_ 1792331058547523584
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>11864nam a22004453i 4500</leader><controlfield tag="001">5006455780</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20240229073839.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">240229s2021 xx o ||||0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783030585051</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9783030585044</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5006455780</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL6455780</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1232279931</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC346-429.2</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8106</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Platz, Thomas.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical Pathways in Stroke Rehabilitation :</subfield><subfield code="b">Evidence-Based Clinical Practice Recommendations.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing AG,</subfield><subfield code="c">2021.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2021.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (284 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro -- Preface -- Acknowledgements -- Contents -- Neurobiology of Stroke Recovery -- 1 Changes in Structural Plasticity After Stroke -- 2 Changes in Functional Plasticity After Stroke -- 3 Conclusion Regarding the Neurobiology of Stroke Recovery -- 4 Take Home Message for Clinical Practice in Stroke Rehabilitation -- References -- Clinical Pathways in Stroke Rehabilitation: Background, Scope, and Methods -- 1 Introduction -- 2 Clinical Pathways -- 3 The Evidence Gap -- 4 International Provision of Practice Recommendations -- 5 Scope, Content, and Methodology Used for the Generation of the Practice Recommendations -- 5.1 Scope of the Evidence-Based Clinical Practice Recommendations -- 5.2 Target Users of the Practice Recommendations -- 5.3 Stakeholder Involvement -- 5.3.1 Practice Recommendations Developer Group -- 5.3.2 Integration of Views and Preferences of the Target Population -- 5.4 Methods Used for Evidence Synthesis and Recommendation Development -- 5.4.1 General Remarks -- 5.4.2 Systematic Search -- 5.4.3 Criteria and Methods for Evidence Selection and Data Extraction -- 5.4.4 Critical Appraisal, Level of Evidence, Evidence Synthesis, and Grading its Quality -- 5.4.5 Synthesis of Evidence-Based Recommendations -- 5.4.6 Dissemination, Implementation, Monitoring, and Auditing -- 5.4.7 Process of Updating the Clinical Practice Recommendations -- 5.4.8 Funding of the Work -- 6 Conclusions -- References -- Goal Setting with ICF (International Classification of Functioning, Disability and Health) and Multidisciplinary Team Approach in Stroke Rehabilitation -- 1 Introduction -- 2 Methodological Considerations -- 3 Multidisciplinary Team Building and Coordination -- 3.1 Improving Quality of Stroke Care -- 3.2 Low Access to Rehabilitation -- 3.3 The Chronic Care Model for Stroke Patients.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">4 ICF-Based Common Language in Reporting and Documentation Along the Care Pathway of Stroke Patients -- 4.1 ICF-Based Scales and Assessments -- 4.2 ICF-Based Goal Setting -- 5 Theoretical Background in Goal-Setting Practice -- 5.1 Goal-Setting Theory (Locke and Latham) -- 5.2 Goal Setting and Action Planning (Scobbie) -- 5.3 Goal Achievement and Goal Attainment Scaling -- 5.4 Examples on ICF-Based Goal Setting -- 6 Goal Setting in Stroke Patients in Practice -- 7 Recommendations for Multidisciplinary Team Approach and ICF-Based Goal Setting in Stroke Rehabilitation -- 8 Summary -- References -- Disorders of Consciousness -- 1 Introduction -- 2 Methods -- 3 DoC Assessment: Clinical Behavioral and Instrumental Diagnostic Tools -- 3.1 Clinicals and Behavioral Tools for DoC Assessments -- 3.2 Instrumental Diagnostic Tools for DoC Assessment -- 4 DoC Rehabilitation -- 5 Pharmacological Therapies for DoC -- 6 Other Specific Therapies for DoC -- References -- Airway and Ventilation Management -- 1 Introduction -- 2 Clinical Evidence and Reasoning -- 2.1 Weaning of Neurological Patients -- 2.2 Existing Studies on Weaning Success -- 2.3 Difficulties in the Weaning Process -- 2.4 Weaning Strategies -- 2.5 Weaning Protocols and Special Ventilation Techniques -- 2.6 Special Features of Prolonged Weaning in Neurological Patients -- 2.6.1 Definition of Successful Weaning from Mechanical Ventilation -- 2.6.2 Invasive and Non-Invasive Ventilation -- 2.6.3 Accompanying Neurological-Neurosurgical (Early) Rehabilitation -- 3 Clinical Practice Recommendations for Weaning in Stroke Patients (and Other Patients with Neurological Conditions) -- 3.1 Methodological Explanations -- 3.2 Recommendations -- 3.2.1 Organizational Setting -- 3.2.2 Weaning Strategy -- 3.2.3 Weaning Process Characteristics -- References -- Recovery of Swallowing.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">1 Introduction -- 2 Dysphagia Screening Early after Stroke -- 3 Instrumental Assessments to Detect Dysphagia or Aspiration -- 4 Treatment of Dysphagia -- 4.1 Behavioral Interventions -- 4.2 Neuromuscular Electrical Stimulation (NMES) -- 4.3 Acupuncture -- 4.4 Noninvasive Brain Stimulation (NIBS) -- 4.5 Oral Hygiene -- 5 Enteral Tube Feedings -- 6 Summary -- References -- Arm Rehabilitation -- 1 Introduction -- 2 Methods for the Best Evidence Synthesis -- 3 Assessment -- 3.1 Measures of Impairment -- 3.1.1 Active Motor Control -- 3.1.2 Spasticity/Resistance to Passive Movement -- 3.2 Measures of Arm, Hand, and/or Finger Function -- 3.3 Measure of Self-Perceived Usefulness of the Affected Arm in Daily Life -- 4 Therapy -- 4.1 Training -- 4.1.1 Dosage of the Therapeutic Time Prescribed and Organizational Forms of Therapy -- 4.1.2 "Schools" of Therapy -- 4.1.3 Type of Feedback Given -- 4.1.4 Bilateral Training -- 4.1.5 Impairment-Oriented Training -- 4.1.6 Task-Specific Training -- 4.1.7 Constraint-Induced Movement Therapy (CIMT) -- 4.1.8 Strength Training -- 4.1.9 Mirror Therapy -- 4.1.10 Mental Practice -- 4.1.11 Action Observation -- 4.1.12 Music Therapy and Rhythmic Auditory Stimulation -- 4.2 Technology-Supported Training -- 4.2.1 Passive Devices for Repetitive Arm and Hand Training -- 4.2.2 Trunk Restraint -- 4.2.3 Splints and Strapping -- 4.2.4 Arm Rehabilitation Using Virtual Reality (VR) Applications -- 4.2.5 EMG- and Neuro-Biofeedback -- 4.2.6 Neuromuscular Electrical Stimulation (NMES) -- 4.2.7 Arm Robot Therapy -- 4.2.8 Repetitive Transcranial Magnetic Stimulation (rTMS) -- 4.2.9 Repetitive Peripheral Magnetic Stimulation (rPMS) -- 4.2.10 Transcranial Direct Current Stimulation (tDCS) -- 4.2.11 Somatosensory Stimulation -- 4.2.12 Acupuncture -- 4.2.13 Investigational Devices -- 4.3 Medication.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">4.3.1 Botulinum Neurotoxin A (BoNT A) -- 4.3.2 Drugs to Enhance Recovery -- 5 Clinical Pathway and Practice Recommendations -- 5.1 General Comments -- 5.2 Dosage and Organization of Treatment -- 5.2.1 Acute and Subacute Phase After Stroke -- 5.2.2 Chronic Phase After Stroke -- 5.3 Therapeutic Options (Table 1) -- 5.3.1 Therapeutic Options for Stroke Survivors with Severe Paresis -- 5.3.2 Therapeutic Options for Stroke Survivors with Moderate and Mild Paresis -- 5.3.3 Therapeutic Options Independent of Stage of Disease or Severity of Paresis -- References -- Mobility After Stroke: Relearning to Walk -- 1 Introduction -- 2 Best Evidence for Rehabilitations of Gait: Methodology -- 3 Early Intensive Training in the Acute Phase (24 H) After Stroke -- 4 Restoration of Gait in Severely Affected Patients Who cannot Walk Without Help -- 4.1 Discussion: Restoration of Gait in Non-Ambulatory Patients -- 4.2 Summary -- 5 Improvement of Gait in Patients Who Walk Independently or With Little Help -- 5.1 Discussion: Improving Walking Ability in Ambulatory and Nearly Ambulatory Patients -- 5.2 Summary -- 6 Improvement of Balance, Reduction of Falls -- 6.1 Discussion: Improvement of Balance, Reduction of Falls -- 6.2 Summary -- 7 Improvement of Walking Speed -- 7.1 Discussion: Improvement of Walking Speed -- 7.2 Summary -- 8 Improvement of Walking Distance -- 8.1 Discussion: Increasing Walking Distance -- 8.2 Summary -- 9 General Discussion and Conclusions -- References -- Post-Stroke Spasticity -- 1 Introduction -- 2 Methods Used for Evidence Synthesis and Practice Recommendations -- 3 Problem Identification and Clinical Assessment -- 4 Treatment Goal Setting -- 4.1 Goal Setting -- 4.2 Goal Attainment Scaling -- 5 Pharmacological and Surgical Treatment -- 5.1 Systemic Medications -- 5.2 Botulinum Toxin Treatment.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">5.2.1 Treatment Outcomes: Upper Limbs -- 5.2.2 Treatment Outcomes: Lower Limbs -- 5.2.3 Treatment Outcomes: Spasticity- or Spasm-Associated Pain -- 5.2.4 Botulinum Toxin A Injection Guidance -- 5.2.5 BoNT-A Products -- 5.2.6 BoNT-A Dosing -- 5.2.7 Adjuvant Therapies to BoNT-A -- 5.3 Neurolysis -- 5.4 Intrathecal Baclofen (ITB) -- 5.5 Surgical Management -- References -- Rehabilitation of Communication Disorders -- 1 Introduction: The Clinical Problem -- 1.1 Aphasia -- 1.2 Dysarthria -- 1.3 Apraxia -- 2 Recommendations for the Assessment and Treatment of Post-Stroke Communication Disorders -- 2.1 Clinical Assessment of Communication Disorders -- 2.2 Behavioural Therapy Interventions -- 2.2.1 Aphasia Therapy -- Impairment Focus -- Activity/Participation Focus -- 2.2.2 Dysarthria Therapy -- 2.2.3 Apraxia of Speech -- 2.3 Biological Therapies -- 2.3.1 Pharmacological Treatments -- 2.3.2 Non-Invasive Brain Stimulation (NIBS) -- 2.4 Timing, Intensity, Dose and Duration of Therapy -- 2.4.1 Timing -- 2.4.2 Intensity, Dose and Duration -- 2.5 Methods of Therapy Delivery -- 2.5.1 Group Therapy -- 2.5.2 Use of Volunteers -- 2.5.3 Use of Computers/Telepractice -- 2.6 Alternative and Augmentative Communication -- 2.7 Communication Environment -- 2.7.1 Conversation/Communication Partner Training -- 2.8 Psychosocial Interventions to Manage Mood Disorders Secondary to Aphasia -- 3 Top Ten Best Practice Recommendations for Aphasia and Forthcoming Information -- References -- Treating Neurovisual Deficits and Spatial Neglect -- 1 Neurovisual Disorders After Brain Damage -- 1.1 Assessment of Neurovisual Disorders -- 1.2 Therapy of Neurovisual Disorders -- 1.2.1 Saccadic Compensation (or Scanning) Training -- 1.2.2 Hemianopic Reading Training -- 1.2.3 Compensatory or Restorative Visual Field Training?.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">1.2.4 Ineffective or Disadvantageous Therapies in VFDs.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="590" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. </subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Platz, Thomas</subfield><subfield code="t">Clinical Pathways in Stroke Rehabilitation</subfield><subfield code="d">Cham : Springer International Publishing AG,c2021</subfield><subfield code="z">9783030585044</subfield></datafield><datafield tag="797" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6455780</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>